多维自纳米调节器通过改善外/内神经元恒常性来促进阿尔茨海默病的治疗
Yixian Li1, Peng Yang1, Ran Meng1
1Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai 201203, China.
Acta pharmaceutica Sinica. B
|March 15, 2024
概括
这项研究开发了一种针对神经元和微质细胞的新型纳米药物,以增强自和溶酶体功能,有效清除有毒蛋白质并减少阿尔茨海默病模型中的神经炎症.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 的特点是神经内蛋白质聚合和微环境问题,导致神经元死亡.
- 自功能障碍,包括神经元和微质细胞的下调和溶酶体缺陷,显著导致AD病理.
- 针对神经元和微质中的自诱导和溶酶体功能的多维策略对于有效的AD治疗至关重要.
研究的目的:
- 设计和评估一种用于阿尔茨海默病治疗的新型纳米药物.
- 开发一种针对神经元和微质细胞的多维自调节器.
- 研究自诱导和溶酶体增强的联合作用,以清除神经毒性聚合物.
主要方法:
- 设计的RP-1改性,ROS响应性小粒 (RT-NM) 载有拉巴素 (自诱导剂) 和基酸十七 (溶解体增强剂).
- 利用RP-1,向高级糖化终产品 (RAGE) 的受体,以有效地传递到AD受影响区域的神经元和微质.
- 向3×Tg-AD转基因小鼠注射RT-NM以评估治疗疗效.
主要成果:
- RT-NM成功地准了神经元和微质细胞,激活了完整的自-溶解体通路.
- 纳米组合疗法增强了神经毒性聚合物 (Aβ) 和炎症体的降解.
- 在AD小鼠中,治疗导致蛋白质负担降低,神经炎症减轻,记忆缺陷改善.
结论:
- 开发了一种用于阿尔茨海默病治疗的多维自纳米调节器 (RT-NM).
- 这种方法有效地促进了以自为中心的治疗,同时诱导自和改善溶酶体功能.
- 该策略在增强病理蛋白质的清除和改善阿尔茨海默症症状方面表现有前途.
相关概念视频
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:36Delivery Pathways to the Lysosome
6.5K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K
01:22Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
01:26Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K